Total Payments
$20,372
2024 Payments
$2,590
Companies
30
Transactions
252
Medicare Patients
19,645
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$10,250 (50.3%)
Food & Beverage$6,812 (33.4%)
Travel$3,250 (16.0%)
Consulting$40.00 (0.2%)
Gifts$10.68 (0.1%)
Education$10.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,250 | 5 | 35.6% |
| Food and Beverage | $6,812 | 231 | 33.4% |
| Travel and Lodging | $3,250 | 11 | 16.0% |
| Honoraria | $3,000 | 2 | 14.7% |
| Consulting Fee | $40.00 | 1 | 0.2% |
| Gift | $10.68 | 1 | 0.1% |
| Education | $10.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $9,464 | 31 | $0 (2024) |
| Medtronic Vascular, Inc. | $3,389 | 38 | $0 (2020) |
| Aziyo Biologics, Inc. | $3,308 | 12 | $0 (2019) |
| Biosense Webster, Inc. | $1,884 | 54 | $0 (2024) |
| Amgen Inc. | $394.46 | 20 | $0 (2024) |
| Braemar Manufacturing, LLC | $325.83 | 2 | $0 (2018) |
| Medtronic, Inc. | $292.83 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $227.88 | 19 | $0 (2024) |
| PFIZER INC. | $145.13 | 9 | $0 (2024) |
| Bardy Diagnostics, Inc. | $128.00 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,590 | 53 | Boston Scientific Corporation ($1,679) |
| 2023 | $7,915 | 46 | Boston Scientific Corporation ($7,383) |
| 2022 | $506.59 | 32 | Biosense Webster, Inc. ($240.16) |
| 2021 | $337.46 | 7 | Biosense Webster, Inc. ($252.04) |
| 2020 | $319.91 | 11 | Biosense Webster, Inc. ($248.71) |
| 2019 | $3,950 | 28 | Aziyo Biologics, Inc. ($3,176) |
| 2018 | $3,747 | 49 | Medtronic Vascular, Inc. ($3,074) |
| 2017 | $1,006 | 26 | BOSTON SCIENTIFIC CORPORATION ($245.61) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $20.87 | General |
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.31 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: General - Therapies_Non Divisional | ||||||
| 09/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardiology | ||||||
| 09/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/03/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 08/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $28.52 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 57 | 5,012 | 7,830 | $1.8M | $635,238 |
| 2022 | 50 | 3,901 | 6,220 | $1.1M | $428,018 |
| 2021 | 59 | 5,227 | 8,107 | $1.4M | $529,998 |
| 2020 | 57 | 5,505 | 8,655 | $1.5M | $557,632 |
Total Patients
19,645
Total Services
30,812
Medicare Billing
$2.2M
Procedure Codes
246
All Medicare Procedures & Services
246 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 677 | 904 | $196,993 | $78,212 | 39.7% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 31 | 32 | $170,944 | $66,842 | 39.1% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 57 | 57 | $168,378 | $64,496 | 38.3% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 89 | 180 | $143,640 | $55,923 | 38.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 305 | 305 | $126,270 | $41,816 | 33.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 98 | 98 | $94,276 | $31,516 | 33.4% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 39 | 40 | $97,640 | $31,117 | 31.9% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 71 | 71 | $79,733 | $28,777 | 36.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 165 | 661 | $74,693 | $26,696 | 35.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 169 | 174 | $51,490 | $21,496 | 41.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 98 | 196 | $46,256 | $17,172 | 37.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 305 | 308 | $45,892 | $16,006 | 34.9% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 21 | 21 | $41,517 | $15,299 | 36.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 80 | 82 | $34,030 | $11,076 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $29,058 | $9,943 | 34.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 798 | 995 | $33,830 | $9,672 | 28.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 186 | 187 | $26,554 | $9,353 | 35.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 160 | 386 | $24,318 | $8,031 | 33.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 91 | 128 | $14,898 | $6,850 | 46.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 61 | $12,993 | $5,651 | 43.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 90 | $13,410 | $5,634 | 42.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 54 | 307 | $16,578 | $5,591 | 33.7% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 13 | 13 | $13,273 | $4,936 | 37.2% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 17 | 17 | $12,920 | $4,731 | 36.6% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 31 | 32 | $11,360 | $4,444 | 39.1% |
About Dr. Michael Jansen, MD
Dr. Michael Jansen, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1740302587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Jansen, MD has received a total of $20,372 in payments from pharmaceutical and medical device companies, with $2,590 received in 2024. These payments were reported across 252 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,250).
As a Medicare-enrolled provider, Jansen has provided services to 19,645 Medicare beneficiaries, totaling 30,812 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 246 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Cardiovascular Disease
- Location Gainesville, FL
- Active Since 04/04/2007
- Last Updated 08/25/2016
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1740302587
Products in Payments
- ECM Patch,Pouch (Device) $3,176
- SelectSecure (Device) $1,344
- Micra (Device) $990.26
- Carto 3 System (Device) $896.22
- CARTO 3 (Device) $661.72
- Cardiac Monitoring Suite (Device) $325.83
- ELIQUIS (Drug) $268.89
- Carto 3 (Device) $252.04
- Repatha (Biological) $233.76
- WATCHMAN (Device) $155.98
- Corlanor (Drug) $150.70
- COBALT DR MRI SURESCAN (Device) $134.88
- Connect HF (Device) $134.01
- Carnation Ambulatory Monitor (Device) $128.00
- XARELTO (Drug) $127.34
- ECM Patch (Device) $107.83
- RESONATE EL ICD VR (Device) $97.51
- CAMZYOS (Drug) $92.59
- INTELLAMAP (Device) $89.63
- ENTRESTO (Drug) $78.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Cardiac Electrophysiology Doctors in Gainesville
Dr. Alok Gambhir, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $131,564
Clinical Cardiac Electrophysiology $131,564
Dr. William Miles, Md, MD
Clinical Cardiac Electrophysiology — Payments: $95,731
Clinical Cardiac Electrophysiology $95,731
Dr. Joshua Lovelock, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $36,458
Clinical Cardiac Electrophysiology $36,458
Dr. Thomas Burkart, Md, MD
Clinical Cardiac Electrophysiology — Payments: $15,289
Clinical Cardiac Electrophysiology $15,289
Dr. Joon Ahn, Md, MD
Clinical Cardiac Electrophysiology — Payments: $11,919
Clinical Cardiac Electrophysiology $11,919
Dr. Shalabh Chandra, Md, MD
Clinical Cardiac Electrophysiology — Payments: $11,872
Clinical Cardiac Electrophysiology $11,872